100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Test Bank For Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion Chapter 1-58 CA$24.71
Add to cart
Quickly navigate to
Preview
  2.  
  3. Pharmacology A Patient-centered Nursing Pro
  4.  
  5. Pharmacology A patient-centered nursing pro

Exam (elaborations)

Test Bank For Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion Chapter 1-58
 19 views  0 purchase
  • Course
  • Pharmacology A patient-centered nursing pro
  • Institution
  • Pharmacology A Patient-centered Nursing Pro
  • Book
  • Pharmacology

Test Bank For Pharmacology A Patient-Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion Chapter 1-58

Preview 4 out of 368  pages

Document information

  • May 30, 2024
  • 368
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers

Subjects

  • pharmacology a patient centered nursing process

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

  • Test Bank - Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2017) PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
  • Pharmacology: A Patient-Centered Nursing Process Approach (9th Edition, 2017) PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
  • PHARMACOLOGY A Patient-Centered Nursing Process Approach TEST BANK 9TH EDITION by MCCUISTION ALL CHAPTERS ISBN:9780323399159
All for this textbook (30)

Written for

  • Pharmacology A patient-centered nursing pro
All documents for this subject (1)

Seller

avatar-seller
nursingrevisions

Reviews received

Content preview

TEST BANK
Pharmacology a patient-centered nursing process approach 11th Edition
by Linda E. McCuistion

,Table Of Content

Chapter 01: The Nursing Process and Patient-Centered Care........................................................................ 4
Chapter 02: Drug Development and Ethical Considerations ......................................................................... 9
Chapter 03: Pharmacokinetics and Pharmacodynamics............................................................................... 17
Chapter 04: Pharmacogenetics ..................................................................................................................... 30
Chapter 05: Complementary and Alternative Therapies .............................................................................. 33
Chapter 06: Pediatric Considerations ........................................................................................................... 38
Chapter 07: Geriatric Considerations ........................................................................................................... 45
Chapter 08: Drugs in Substance Use Disorder ............................................................................................. 50
Chapter 09: Safety and Quality .................................................................................................................... 56
Chapter 10: Drug Administration................................................................................................................. 62
Chapter 11: Drug Calculations ..................................................................................................................... 67
Chapter 12: Fluid Volume and Electrolytes ................................................................................................. 71
Chapter 13: Vitamin and Mineral Replacement ........................................................................................... 80
Chapter 14: Nutritional Support ................................................................................................................... 87
Chapter 15: Adrenergic Agonists and Antagonists ...................................................................................... 94
Chapter 16: Cholinergic Agonists and Antagonists ................................................................................... 100
Chapter 17: Stimulants ............................................................................................................................... 106
Chapter 18: Depressants ............................................................................................................................. 110
Chapter 19: Antiseizure Drugs ................................................................................................................... 117
Chapter 20: Drugs for Parkinsonism and Alzheimer Disease .................................................................... 123
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms ...................................................... 130
Chapter 22: Antipsychotics and Anxiolytics .............................................................................................. 135
Chapter 23: Antidepressants and Mood Stabilizers ................................................................................... 142
Chapter 24: Antiinflammatories ................................................................................................................. 149
Chapter 25: Analgesics............................................................................................................................... 156
Chapter 26: Penicillins, Other Beta-Lactams, and Cephalosporins ........................................................... 162
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides ... 167
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones ............................. 171
Chapter 29: Sulfonamides and Nitroimidazoles Antibiotics ...................................................................... 175
Chapter 30: Antituberculars, Antifungals, and Antivirals.......................................................................... 179
Chapter 31: Antimalarials, Anthelmintics, and Peptides ........................................................................... 187
Chapter 32: HIV- and AIDS-Related Drugs .............................................................................................. 191
Chapter 33: Transplant Drugs .................................................................................................................... 195
Chapter 34: Vaccines ................................................................................................................................. 197
Chapter 35: Anticancer Drugs .................................................................................................................... 201
Chapter 36: Targeted Therapies to Treat Cancer ....................................................................................... 206
2|Page

,Chapter 37: Biologic Response Modifiers ................................................................................................. 211
Chapter 38: Upper Respiratory Disorders .................................................................................................. 216
Chapter 39: Lower Respiratory Disorders ................................................................................................. 222
Chapter 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics ..................................................... 230
Chapter 41: Diuretics ................................................................................................................................. 240
Chapter 42: Antihypertensives ................................................................................................................... 246
Chapter 43: Anticoagulants, Antiplatelets, and Thrombolytics ................................................................. 255
Chapter 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow...................................... 265
Chapter 45: Gastrointestinal Tract Disorders ............................................................................................. 272
Chapter 46: Antiulcer Drugs ...................................................................................................................... 281
Chapter 47: Eye and Ear Disorders ............................................................................................................ 289
Chapter 48: Dermatologic Disorders.......................................................................................................... 294
Chapter 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders......................................................... 301
Chapter 50: Antidiabetics ........................................................................................................................... 311
Chapter 51: Urinary Disorders ................................................................................................................... 320
Chapter 52: Pregnancy and Preterm Labor ................................................................................................ 327
Chapter 53: Labor, Delivery, and Postpartum............................................................................................ 336
Chapter 54: Neonatal and Newborn ........................................................................................................... 343
Chapter 55: Women’s Reproductive Health .............................................................................................. 346
Chapter 56: Men’s Health and Reproductive Disorders ............................................................................ 355
Chapter 57: Sexually Transmitted Infections ............................................................................................. 361
Chapter 58: Adult and Pediatric Emergency Drugs ................................................................................... 365




3|Page

, Chapter 01: The Nursing Process and Patient-Centered Care
McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition


MULTIPLE CHOICE

1. All of the following would be considered subjective data, EXCEPT:
a. Patient-reported health history
b. Patient-reported signs and symptoms of their illness
c. Financial barriers reported by the patient’s caregiver
d. Vital signs obtained from the medical record
ANS: D
Subjective data is based on what patients or family members communicate to the nurse. Patient-
reported health history, signs and symptoms, and caregiver reported financial barriers would be
considered subjective data. Vital signs obtained from the medical record would be considered
objective data.

DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Client Care

2. The nurse is using data collected to define a set of interventions to achieve the most desirable
outcomes. Which of the following steps is the nurse applying?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)
c. Generate solutions (planning)
d. Take action (nursing interventions)
ANS: C
When generating solutions (planning), the nurse identifies expected outcomes and uses the
patient’s problem(s) to define a set of interventions to achieve the most desirable outcomes.
Recognizing cues (assessment) involves the gathering of cues (information) from the patient
about their health and lifestyle practices, which are important facts that aid the nurse in making
clinical care decisions. Prioritizing hypothesis is used to organize and rank the patient problem(s)
identified. Finally, taking action involves implementation of nursing interventions to accomplish
the expected outcomes.

DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Client Care

3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes of
hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has to be
done to care for their child. The nurse reviews medications, diet, and symptom management with
the parents and draws up a daily checklist for the family to use. These activities are completed in
which step of the nursing process?
a. Recognizing cues (assessment)
b. Analyze cues & prioritize hypothesis (analysis)




4|Page

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller nursingrevisions. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$24.71. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

52510 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
CA$24.71
  • (0)
Add to cart
Added